Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Wuxi Biologics (Cayman) (1FW2) vs. Competitors

5 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1FW2Wuxi Biologics (Cayman)EUR 5.14EUR 22.16B33.3746.94%Strong BuyUnlock the DE:1FW2 analyst price target with TipRanks PremiumDE:1FW2Unlock the DE:1FW2 top-analyst price target with TipRanks Premium
HK:1548Genscript BiotechHKD 30.16HKD 67.32B-13.1884.69%Strong BuyUnlock the HK:1548 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1548Unlock the HK:1548 top-analyst price target with TipRanks Premium
HK:3759Pharmaron Beijing Co., Ltd. Class HHKD 26.44HKD 78.72B40.8220.29%Strong BuyUnlock the HK:3759 analyst price target with TipRanks PremiumDE:1FW2 vs HK:3759Unlock the HK:3759 top-analyst price target with TipRanks Premium
HK:1521Frontage Holdings Corp.HKD 2.07HKD 4.25B51.1195.28%―Unlock the HK:1521 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1521Unlock the HK:1521 top-analyst price target with TipRanks Premium
HK:1873Viva Biotech HoldingsHKD 1.15HKD 2.43B12.11-40.72%―Unlock the HK:1873 analyst price target with TipRanks PremiumDE:1FW2 vs HK:1873Unlock the HK:1873 top-analyst price target with TipRanks Premium
HK:2315Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class HHKD 36.92HKD 16.42B36.9621.85%―Unlock the HK:2315 analyst price target with TipRanks PremiumDE:1FW2 vs HK:2315Unlock the HK:2315 top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%200%250%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1FW2Wuxi Biologics (Cayman)5.141.5944.79%
HK:1548Genscript Biotech30.1614.2889.92%
HK:3759Pharmaron Beijing Co., Ltd. Class H26.444.8622.54%
HK:1521Frontage Holdings Corp.2.070.9889.91%
HK:1873Viva Biotech Holdings1.15-0.82-41.62%
HK:2315Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H36.924.9215.38%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts